Marble, columns and stairs
Marble, columns and stairs
https://mcmillan.ca/wp-content/uploads/2017/11/dealscases_desktop.jpg
post

McMillan Advises Sunwing Airlines on its Successful Merger with the WestJet Group

May 1, 2023

On May 1, 2023, Sunwing Airlines completed its merger with The WestJet Group. This marks the third successful airline merger in Canada within the last two decades.

post

McMillan’s Strategy Leads to Successful Auction that Generated Exceptionally Strong Results for Creditors

Apr 21, 2023

SLP Holdings Ltd., Structurlam Mass Timber Corporation, Structurlam Mass Timber U.S., Inc. and Natural Outcomes, LLC commenced proceedings by filing voluntary petitions for relief pursuant to Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.

post

Circa Completes Amalgamation with Sicane Group SAS and Spinout of Telecom Assets

Apr 14, 2023

On April 14, 2023, Circa Enterprises Inc. (TSVX: CTO) ("Circa") and Sicame Group SAS ("Sicame") announced the completion of the amalgamation of Circa and 2023 Sicame Amalco Inc. ("SubCo") (the "Amalgamation") pursuant to the amalgamation agreement among Circa, Sicame Canada Holdings Inc.

post

McMillan Advises Thoma Bravo in its $1.8 Billion Acquisition of Magnet Forensics Inc.

Apr 6, 2023

On April 6, 2023, Thoma Bravo successfully completed the acquisition of all of the issued and outstanding subordinate voting shares and multiple voting shares of Magnet Forensics Inc. (“Magnet”) (TSX: MAGT) for $1.8 Billion, by way of a plan of arrangement.  

post

McMillan Advises W.P. Carey on its USD$468 Million Sale-leaseback of Pharmaceutical Campuses

Apr 4, 2023

On April 4, 2023, W. P. Carey completed its USD$468 million sale-leaseback of an industrial portfolio of four pharmaceutical research and development and advanced manufacturing campuses in the Greater Toronto Area.

post

McMillan Advises SK Capital on its Acquisition of Apotex Pharmaceuticals

Apr 3, 2023

On April 3, 2023, an affiliate of funds advised by SK Capital Partners, LP completed its previously announced agreement to acquire Apotex Pharmaceutical Holdings Inc.

post

Canada Infrastructure Bank invests up to $100 Million in Ameresco as Part of the Building Retrofits Initiative

Mar 31, 2023

McMillan LLP acted as counsel to the Canada Infrastructure Bank (“CIB”) on its financing to Ameresco Canada Inc. (“Ameresco”) as part of the Building Retrofits Initiative (BRI)

post

Canada Infrastructure Bank’s $100 Million Financing to IonicBlue for Energy Eficiency Projects Across Canada

Mar 31, 2023

IonicBlue CleanEnergy Inc., a wholly owned subsidiary of IonicBlue, closed on a $100 million credit facility with the Canada Infrastructure Bank.

post

Canada Infrastructure Bank Commits $25 Million to Modern Niagara’s Large Scale Commercial Retrofit

Mar 28, 2023

McMillan LLP acted as counsel to the Canada Infrastructure Bank (“CIB”) on its financing to the Modern Niagara Group (“Modern Niagara”), as part of the Building Retrofits Initiative (BRI).